Leveraging a Preexisting Global Infectious Disease Network for Local Decision Making During a Pandemic.

COVID-19 clinical communicable diseases disease outbreaks health emergencies networking

Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
01 03 2022
Historique:
received: 20 06 2021
pubmed: 29 7 2021
medline: 8 3 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

Emerging infectious disease epidemics require a rapid response from health systems; however, evidence-based consensus guidelines are generally absent early in the course of events. Formed in 2017 by 5 high-level isolation units spanning 3 continents, the experience of the Global Infectious Disease Preparedness Network (GIDPN) early in the course of coronavirus disease 2019 (COVID-19) provides a model for accelerating best practice development and improving decision-making in health emergencies. The network served as a platform for real-time, open and transparent information-sharing during unknowns of an active outbreak by clinicians caring for patients, by researchers conducting clinical trials and transmission and infection prevention studies, and by teams advising local and national policy makers. Shared knowledge led to earlier adoption of some treatment modalities as compared to most peer institutions and to implementation of protocols prior to incorporation into national guidelines. GIDPN and similar networks are integral in enhancing preparedness for and response to future epidemics/pandemics.

Identifiants

pubmed: 34318871
pii: 6329401
doi: 10.1093/cid/ciab660
pmc: PMC8406886
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

729-733

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

Jocelyn J Herstein (JJ)

Department of Environmental, Agricultural, and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.

John J Lowe (JJ)

Department of Environmental, Agricultural, and Occupational Health, College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Timo Wolf (T)

Department of Infectious Diseases, University Hospital Frankfurt, Frankfurt am Main, Germany.

Shawn Vasoo (S)

National Centre for Infectious Diseases, Singapore, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.

Yee Sin Leo (YS)

National Centre for Infectious Diseases, Singapore, Singapore.
Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.

Bum Sik Chin (BS)

Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea.

Yinzhong Shen (Y)

Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.

Angela L Hewlett (AL)

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

James V Lawler (JV)

Division of Infectious Diseases, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH